Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals

European Journal of Immunology

Volumn 29, Issue 4, 1999, Pages 1076-1085

  André, Pascale ^a   Brunet, Corinne ^b   Guia, Sophie ^a   Gallais, Hervé ^b   Sampol, José ^b,c   Vivier, Eric ^a,b   Dignat George, Françoise ^b,c  

^a INSERM   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

HIV 1; KIR; NK cell; NK cell receptor; T cell

Indexed keywords

CD4 ANTIGEN; CD94 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

EID: 0032929792     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199904)29:04<1076::aid-immu1076>3.0.co;2-z     Document Type: Article

References (57)

1. Robertson, M. J. and Ritz, J., Biology and clinical relevance of human natural killer cells. Blood 1990. 76: 2421-2438.
2. Lanier, L. L. and Philips, J. H., Natural killer cells. Curr. Opin. Immunol. 1992. 4: 38-42.
3. Warren, H. S., NK cell proliferation and inflammation. Immunol. Cell Biol. 1997. 74: 473-480.
4. Oliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., Li, Y., Romano, J. W. and Fauci, A. S., Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 1998. 102: 223-231.
5. Asai, O., Longo, D. L., Tian, Z. G., Hornung, R. L., Taub, D. D., Ruscetti, F. W. and Murphy, W. J., Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 1998. 101: 1835-1842.
6. Mehrotra, P. T., Donnelly, R. P., Wong, S., Kanegane, H., Geremew, A., Mostowski, H. S., Furuke, K., Siegel, J. P. and Bloom, E. T., Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 1998. 160: 2637-2644.
7. Moretta, A. and Moretta, L., HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 1997. 9: 694-701.
8. Lanier, L. L., NK Cell Receptors. Annu. Rev. Immunol. 1998. 16: 359-393.
9. Long, E. O. and Wagtmann, N., Natural killer cell receptors. Curr. Opin. Immunol. 1997. 9: 344-350.
10. Vivier, E. and Daëron, M., Immunoreceptor Tyrosine-based Inhibition Motifs (ITIMs). Immunol. Today 1997. 18: 286-291.
11. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P. and Long, E. O., Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996. 4: 77-85.
12. Olcese, L., Lang, P., Vély, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K. L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J. C. and Vivier, E., Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 1996. 156: 4531-4534.
13. Binstadt, B. A., Brumbaugh, K. M., Dick, C. J., Scharenberg, A. M., Williams, B. L., Colonna, M., Lanier, L. L., Kinet, J.-P., Abraham, R. T. and Leibson, P. J., Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996. 5: 629-638.
14. Leibson, P. J., Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997. 6: 655-661.
15. Ono, M., Okada, H., Bolland, S., Yanagi, S., Kurosaki, T. and Ravetch, J. V., Deletion of SHIP or SHP-1 reveals two distincts pathways for inhibitory signaling. Cell 1997. 90: 293-301.
16. Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A. and Vivier, E., Killer-cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by human killer cells. J. Immunol. 1997. 158: 5083-5086.
17. Tomasello, E., Olcese, L., Vély, F., Geourgeon, C., Bléry, M., Moqrich, A., Gautheret, D., Djabali, M., Mattei, M.-G. and Vivier, E., Gene structure, expression pattern and biological activity of mouse KAR-associated protein (KARAP)/DAP-12. J. Biol. Chem. 1998. 273: 34115-34119.
18. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. and Phillips, J. H., Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998. 391: 703-707.
19. Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H. and Lanier, L. L., Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 1998. 161: 7-10.
20. Lanier, L. L, Corliss, B., Wu, J. and Phillips, J. H., Association of DAP-12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693-701.
21. - cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995. 10: 331 -340.
22. Scott-Algara, D., Vuillier, F., Cayota, A., Rame, V., Guetard, D., Moncany, M. L., Marasescu, M., Dauguet, C. and Dighiero, G., In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1. J. Gen. Virol. 1993. 74: 725-731.
23. Chehimi, J., Bandyopadhyay, S., Prakash, K., Perussia, B., Hassan, N. F., Kawashima, H., Campbell, D., Kornbluth, J. and Starr, S. E., In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J. Virol. 1991. 65: 1812-1822.
24. Lusso, P., Malnati, M. S., Garzino-Demo, A., Crowley, R. W., Long, E. O. and Gallo, R. C., Infection of natural killer cells by human herpesvirus 6. Nature 1993. 362: 458-462.
25. Ullum, H., Gotzsche, P. C., Victor, J., Dickmeiss, E., Skinhoj, P. and Pedersen, B. K., Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 1995. 182: 789-799.
26. + natural killer cell subset during HIV infection. Cytometry 1995. 22: 10-15.
27. Ruscetti, F. W., Mikovits, J. A., Kalyanaraman, V. S., Overton, H., Stevenson, K., Stromberg, K., Herberman, R. B., Farrar, W. L. and Ortaldo, J. R., Analysis of effector mechanisms against HTLV-1- and HTLV-III/LAV-infected lymphoid cells. J. Immunol. 1986. 136: 3619-3624.
28. Gryllis, C., Wainberg, M. A., Bentwich, Z., Gornitsky, M. and Brenner, B. G., Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals. Clin. Exp. Immunol. 1992. 89: 356-361.
29. Brenner, B. G., Gryllis, C. and Wainberg, M. A., Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J. Leukoc. Biol. 1991. 50: 628-640.
30. Weinhold, K. J., Anti-HIV-1 ADCC: clinical and therapeutic implications. Biotechnol. Ther. 1991. 2: 147-157.
31. Ahmad, A. and Menezes, J., Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. AIDS 1996. 10: 143-149.
32. Ferrini, S., Cambiaggi, A., Meazza, R., Sforzini, S., Marciano, S., Mingari, M. C. and Moretta, L., T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 1994. 24: 2294-2298.
33. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
34. + T cells. Proc. Natl. Acad. Sci. USA 1998. 95: 1172-1177.
35. Halary, F., Peyrat, M.-A., Champagne, E., Lopez-Botet, M., Moretta, A., Moretta, L., Vié, H., Fournié, J.-J. and Bonneville, M., Control of self-reactive cytotoxic T lymphocytes expressing gd T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 1997. 27: 2812-2821.
36. Phillips, J. H., Gumperz, J. E., Parham, P. and Lanier, L. L., Superantigen-dependant, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995. 268: 403-405.
37. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. and Parham, P., The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB-1, a putative HLA receptor. J. Exp. Med. 1995. 181: 1133-1144.
38. Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L. and Parham, P., Human diversity in killer cell inhibitory receptor genes. Immunity 1997. 7: 753-763.
39. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L. and Parham, P., Functionally and structurally distinct NK cell receptor repertories in the peripheral blood of two human donors. Immunity 1997. 7: 739-751.
40. Cauda, R., Coletti, D., Lucia, M. B., Tumbarello, M., Ruini, C., Orengo, A. M. and Moretta, A., Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. Clin. Immunol. Immunopathol. 1994. 70: 198-205.
41. De Maria, A., Ferraris, A., Guastella, M., Pilia, S., Cantoni, C., Polero, L., Mingari, M. C., Basseti, D., Fauci, A. S. and Moretta, L., Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA 1997. 94: 10285-10288.
42. Bottino, C., Sivori, S., Vitale, M., Cantoni, C., Falco, M., Pende, D., Morelli, L., Augugliaro, R., Semenzato, G., Biassoni, R., Moretta, L. and Moretta, A., A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 1996. 26: 1816-1824.
43. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A., Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 1995. 7: 697-703.
44. McMichael, A., T cell response and viral escape. Cell 1998. 93: 673-676.
45. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
46. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795 -799.
47. low NK cells. J. Immunol. 1997 159: 3189-3194.
48. Höglund, P., Sundback, J., Olsson-Alheim, M. Y., Johansson, M., Salcedo, M., Öhlen, C., Ljunggren, H.-G., Sentman, C. L. and Kärre, K., Host MHC class I gene control of NK-cell specificity on the mouse. Immunol. Rev. 1997. 155: 11-28.
49. Held, W., Cado, D. and Raulet, D. H., Transgenic expression of the Ly49A natural killer cell receptor confers class I MHC-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 1996. 184: 2037-2041.
50. Gumperz, J. E., Valiante, N. M., Parham, P., Lanier, L. L. and Tyan, D., Heterogeneous phenotypes of expression of the NKB1 Natural Killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 1996. 183: 1817-1827.
51. Cambiaggi, A., Verthuy, C., Naquet, P., Romagne, F., Ferrier, P., Biassoni, R., Moretta, A., Moretta, L. and Vivier, E., Naturel killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor. Proc. Natl. Acad. Sci. USA 1997. 94: 8088-8092.
52. Zimmer, J., Donato, L., Hanau, D., Cazenave, J. P., Tongio, M. M., Moretta, A. and Salle, H., Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome). J. Exp. Med. 1998. 187: 117-122.
53. Mingari, M. C., Moretta, A. and Moretta, L., Regulation or KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol. Today 1998. 19: 153-157.
54. Le Dréan, E., Vély, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N., Moretta, A., Jotereau, F. and Vivier, E., Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 1998. 28: 264-276.
55. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, M., Augugliaro, R., Barbaresi, M., Ciccone, E. and Moretta, L., p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597-604.
56. Pérez-Villar, J. J., Carretero, M., Navarro, F., Malero, I., Rodriguez, A., Bottino, C., Moretta, A. and Lòpez-Botet, M., Biochemical and serological evidence for the existence of functionally distinct isoforms of the CD94 NK-cell receptor. J. Immunol. 1996. 157: 5367-5374.
57. Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Di Donato, C., Amoroso, A., Malnati, M., Bottino, C., Moretta, L. and Moretta, A., Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Proc. Natl. Acad. Sci. USA 1996. 93: 1453-1457.